TrialBlood cancer journal2025

Optimizing lenalidomide therapy in renal impairment: analysis of renal response in the prospective REMNANT study in transplant-eligible newly diagnosed multiple myeloma.

Frida Bugge Askeland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.